MEGHAN MCGRATH: Open Payments
NPI 1912593773 · WOONSOCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 74 payments from 12 companies in 2025. Trend: 2023 $1,798 · 2024 $1,697 · 2025 $1,693
Food & beverage: $1,667Education: $26
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $407 |
| Lundbeck LLC | 10 | $239 |
| Vanda Pharmaceuticals Inc. | 11 | $174 |
| Teva Pharmaceuticals USA, Inc. | 6 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $151 |
| Neurocrine BioSciences, Inc. | 5 | $140 |
| Janssen Pharmaceuticals, Inc | 5 | $131 |
| Alkermes, Inc. | 5 | $110 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| ABBVIE INC. | 2 | $52 |
Products named: REXULTI, FANAPT, CAPLYTA, AUSTEDO XR, INGREZZA, SPRAVATO, ABILIFY MAINTENA, Sunosi.
Industry payments across RI — which companies pay providers there.
